Search Results for keywords:"Section 337"

The U.S. International Trade Commission is asking for public and government input on possible actions it may take if it finds that certain companies violated trade rules by importing specific computing devices. The issue at hand involves a potential violation of Section 337 of the Tariff Act of 1930, which could lead to limiting or stopping the import of products from companies like ASUSTeK Computer, Acer Inc., and Dell Technologies, among others. The public is invited to submit comments on whether these actions would affect public health, the economy, competition, or consumers in the United States by March 31, 2025. Submissions must be made electronically, and the correct protocol for confidential information must be followed.

The International Trade Commission is considering whether certain vaporizer devices and related components from JUUL Labs, Inc. might violate trade regulations. An administrative law judge issued a preliminary determination on this issue. The Commission is seeking public input regarding the potential impact of restricting these products, focusing on public health, U.S. economy, and consumer effects. Submissions from the public and government agencies, limited to five pages, are due by January 6, 2025.

The U.S. International Trade Commission has announced a notice following a complaint from For Kids By Parents, Inc., regarding accusations of patent infringement. The complaint alleges that certain companies from China have been importing and selling urine splash guards that infringe on two U.S. patents. As a result, the Commission has initiated an investigation to determine if there is a violation of Section 337 of the Tariff Act of 1930. The complainant is seeking exclusion orders and cease and desist orders against the accused companies.

The U.S. International Trade Commission has concluded an investigation regarding the alleged patent infringement by Samsung Display Co., Ltd. (SDC) involving organic light-emitting diode (OLED) display panels. The investigation found no violation of section 337 of the Tariff Act of 1930, ruling that SDC did not demonstrate sufficient domestic industry ties required to support its claims, among other deficiencies. The investigation, which involved multiple parties and reviewed several patents, is now officially terminated with a finding of no violation.

The U.S. International Trade Commission found that certain icemaking machines and components from Bluenix Co., Ltd. infringe on specific U.S. patents held by Hoshizaki America, Inc. As a result, the Commission issued orders to stop these products from being imported into the U.S. and imposed a bond of 49% of the product's value during a review period. This decision follows a series of investigations and reviews confirming the patent violation.

Amphenol Corp. filed a complaint with the U.S. International Trade Commission on December 18, 2020, claiming that certain companies violated the Tariff Act of 1930 by importing and selling specific electrical connectors and cages that infringe on Amphenol's patents. The U.S. International Trade Commission decided to investigate these claims and determine if there was indeed a violation. If the investigation finds a violation, the Commission may issue orders to stop the importation of these products. The Commission has also outlined the process for the accused companies to respond to the complaint.

The U.S. International Trade Commission is seeking public comments on potential public interest issues related to a possible violation of Section 337 of the Tariff Act of 1930. The investigation involves certain bone cements and bone cement accessories imported by Heraeus Medical GmbH and Heraeus Medical LLC. If a violation is found, the Commission may issue exclusion and cease and desist orders against these imports. The public is invited to submit comments by March 9, 2021, focusing on how such remedial actions might impact public health, the economy, and consumers in the United States.

The U.S. International Trade Commission has announced that it will review a decision related to Viking Therapeutics, which claims that certain companies, including Ascletis, misused trade secrets for making thyroid hormone drugs. The Commission's review may recommend excluding certain products from the U.S. market and impose sanctions if a section 337 violation is found. They are seeking public input on the potential effects of such actions and how they might impact health, the economy, and consumers. The public and involved parties have until February 28, 2025, to file written submissions addressing these issues.

The U.S. International Trade Commission has started an investigation into alleged patent violations by several tech companies, including Intel and others. The complaint was made by Tela Innovations, Inc., who claim these companies imported and sold certain microprocessors and products in the U.S. that infringe on their patent rights. Tela Innovations wants the Commission to stop these imports and sales with an exclusion order and cease and desist orders. A hearing will determine the validity and scope of these allegations, and involved parties must respond to the complaint by a specific deadline to avoid default judgments.

The U.S. International Trade Commission found a violation of section 337 of the Tariff Act of 1930 related to certain liquid transfer devices and issued a limited exclusion order and a cease and desist order. The original complaint, filed by West Pharmaceutical Services, claimed infringement of a U.S. patent by products imported into the U.S. from three companies. After a thorough investigation, the Commission confirmed the infringement of the patent and ruled that no bond was necessary because the public interest would not be harmed by the orders. Commissioner Kearns disagreed with the final decision and provided a separate opinion.